Selway Asset Management reduced its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) by 6.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,300 shares of the company’s stock after selling 3,400 shares during the period. Express Scripts Holding comprises approximately 1.9% of Selway Asset Management’s investment portfolio, making the stock its 17th largest position. Selway Asset Management’s holdings in Express Scripts Holding were worth $3,275,000 as of its most recent filing with the SEC.

Other hedge funds also recently added to or reduced their stakes in the company. Park National Corp OH increased its position in Express Scripts Holding by 0.3% in the second quarter. Park National Corp OH now owns 3,575 shares of the company’s stock worth $228,000 after buying an additional 11 shares in the last quarter. Parkside Financial Bank & Trust increased its position in shares of Express Scripts Holding by 0.3% in the second quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock worth $551,000 after buying an additional 23 shares during the period. Carroll Financial Associates Inc. increased its position in shares of Express Scripts Holding by 1.0% in the second quarter. Carroll Financial Associates Inc. now owns 3,186 shares of the company’s stock worth $203,000 after buying an additional 30 shares during the period. CAPROCK Group Inc. increased its position in shares of Express Scripts Holding by 0.9% in the second quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock worth $235,000 after buying an additional 33 shares during the period. Finally, Honkamp Krueger Financial Services Inc. increased its position in shares of Express Scripts Holding by 0.8% in the second quarter. Honkamp Krueger Financial Services Inc. now owns 4,762 shares of the company’s stock worth $304,000 after buying an additional 38 shares during the period. Institutional investors own 88.70% of the company’s stock.

Express Scripts Holding Company (NASDAQ ESRX) opened at 60.79 on Monday. Express Scripts Holding Company has a 12-month low of $57.80 and a 12-month high of $77.50. The company’s 50-day moving average price is $61.89 and its 200-day moving average price is $63.95. The stock has a market cap of $35.11 billion, a PE ratio of 10.55 and a beta of 0.90.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping analysts’ consensus estimates of $1.71 by $0.02. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The company had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. During the same quarter in the prior year, the company posted $1.57 EPS. The business’s revenue for the quarter was up .5% compared to the same quarter last year. On average, equities analysts expect that Express Scripts Holding Company will post $6.99 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Express Scripts Holding Company (ESRX) Shares Sold by Selway Asset Management” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/28/express-scripts-holding-company-esrx-shares-sold-by-selway-asset-management.html.

A number of brokerages recently issued reports on ESRX. Morgan Stanley boosted their price objective on Express Scripts Holding from $52.00 to $57.00 and gave the company an “underweight” rating in a research note on Thursday, August 10th. BidaskClub cut Express Scripts Holding from a “sell” rating to a “strong sell” rating in a research report on Friday, August 4th. Cowen and Company reiterated an “outperform” rating and set a $83.00 price target on shares of Express Scripts Holding in a research report on Friday, June 9th. Needham & Company LLC assumed coverage on Express Scripts Holding in a research report on Friday, July 21st. They set a “hold” rating on the stock. Finally, ValuEngine cut shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Four analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $71.17.

In other Express Scripts Holding news, VP Everett Neville sold 1,163 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $61.48, for a total transaction of $71,501.24. Following the transaction, the vice president now owns 18,232 shares of the company’s stock, valued at approximately $1,120,903.36. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.68% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.